ReportWire

Tag: Medicine

  • Merrimac health officials warn about West Nile virus

    Merrimac health officials warn about West Nile virus

    [ad_1]

    MERRIMAC — Town health officials ask residents to take precautions after the discovery of mosquitoes infected with West Nile virus in nearby Haverhill.  

    The insects were among those trapped at a specific mosquito surveillance site, Merrimac Health Agent Deborah Ketchen and the town’s Board of Health announced in a news release Thursday night.  

    The state Department of Public Health later confirmed that the mosquitoes tested positive for the potentially deadly virus, the health officials said.

    The Health Board urged local residents to take proper precautions and offered tips, noting that the town’s risk level for West Nile virus remained the same.

    It was not noted whether these mosquitoes were among those that tested positive for West Nile virus and Eastern equine encephalitis in Haverhill on July 30.

    Last week, Newburyport confirmed a case of West Nile virus in the city and urged its residents to take precautions. None of the cases in either community involve infected humans.

    Haverhill Mayor Melinda Barrett announced on the city’s website Aug. 2 that spraying for mosquitoes would begin three days later in a northeastern section of the community due to the positive findings.

    Trucks from the Northeast Massachusetts Mosquito Control District were to begin spraying the insecticide Zenivex E4 RTU in an area “bounded by Main Street to Kenzoa Avenue to Amesbury Road to Kenzoa Street to Center Street to Millvale Road to East Broadway to Old Ferry Road to Lincoln Avenue to Water Street then back to Main Street,” the city said. 

    Public health surveillance is conduced in the state for both mosquito-borne illnesses. The highest risk for contracting WNV or EEE is from late July to the first fall frost, according to Merrimac officials. 

    Mosquitoes receive WNV and EEE by biting infected birds. People and animals contract these diseases by being bitten by an infected mosquito.

    Most people bitten by mosquitoes carrying WNV will either have no symptoms or very mild symptoms and recover on their own. People over age 50 have the highest risk of becoming seriously ill, the Merrimac officials said. Additional monitoring and testing of mosquitoes in Haverhill was expected.

    Merrimac health officials and Barrett encourage the public to take precautions, including using DEET mosquito repellant, wearing long sleeves and pants, and avoiding outdoor activities from dusk to dawn.

    Residents are also asked to check their property for containers of standing water that could attract mosquitoes. Tightly fitted screens are needed for windows and doors, the officials said.   

    More information about WNV and EEE is available by calling the state Department of Public Health recorded information line at 1-866-MASS-WNV (1-866-627-7968), or the DPH Epidemiology Program at 617-983-6800.

    A fact sheet is available at mass.gov/doc/wnv-factsheet-english/download.

    [ad_2]

    Staff Reports

    Source link

  • The Uncertain Path Forward for Psychedelic Medicine

    The Uncertain Path Forward for Psychedelic Medicine

    [ad_1]

    But psychedelic compounds are tricky to test in this way because their psychedelic effects are so recognizable to those who take them. In the Lykos trials, around 90 percent of the participants were able to correctly guess whether they received MDMA or a placebo, effectively “unblinding” the study.

    If participants knew they received MDMA, they could have been more receptive to the psychotherapy and felt more positive about the trial experience. And if they knew they hadn’t, they might have been predisposed to think that the psychotherapy they received was less effective. Both scenarios could have influenced how they reported their PTSD symptoms after the MDMA sessions.

    “Once you have an unblinded trial, you potentially have all kinds of questions about efficacy,” says David Rind, chief medical officer of the Boston-based nonprofit Institute for Clinical and Economic Review, which published a report in May raising concerns about the validity of the Lykos trial data.

    Blinded trials with a placebo group are often considered the gold standard in medical research, but Rind says there are other ways to ensure reliable results. For instance, instead of giving participants in the control arm an inert placebo, Lykos could administer a safe but active drug that is known to produce some physiological effects. This would at least leave patients in doubt about what they received, Rind says.

    Another issue Lykos will have to address is the therapy part of its treatment. The company says its treatment manual allows for a “personalized experience,” but FDA advisers had concerns about the variability of psychotherapy offered in the trials. Rind says because Lykos was testing its own psychotherapy protocol in both the drug and placebo groups, rather than an established trauma-focused therapy, it’s hard to know how effective the therapy component was.

    One way to address this would be to study an established trauma therapy in combination with MDMA, or test different psychotherapy approaches head-to-head.

    Sandhya Prashad, president of the American Society of Ketamine Physicians, Psychotherapists, and Practitioners, says the therapy component likely complicated Lykos case to the FDA. “I don’t think the FDA knew what to do with that,” she says.

    She thinks the psychedelics field can learn from the 2019 approval of Spravato. Johnson & Johnson asked the FDA to approve just the drug, rather than the drug alongside psychotherapy.

    Because Spravato can induce disassociation and hallucinogenic effects, the FDA has special requirements around how it is prescribed. It must be administered in a certified medical office where a health care provider can monitor the patient. A patient doesn’t get therapy during the session.

    However, Prashad says she understands why Lykos was seeking approval for MDMA combined with psychotherapy. Compare Spravato to generic ketamine, which was approved as an anesthetic in 1970 and is often given off-label as a depression treatment. Giving ketamine off-label doesn’t come with the same FDA requirements. It’s unregulated as a depression treatment, says Prashad. “You see a lot of subpar quality of care. I think Lykos was trying to prevent that and roll this out in a responsible way.”

    Other companies are pursuing psychedelics solely as a drug rather than combining it with psychotherapy. Biotech company Compass Pathways is testing psilocybin, the active compound in magic mushrooms, in Phase 3 trials for treatment-resistant depression. A licensed medical professional prepares participants for the psilocybin session, observes and is present with them during their session, and provides follow-up support after. Sessions can last six to eight hours. The company notes that this type of psychological support is not psychotherapy.

    Similarly, Beckley Psytech is studying a derivative of DMT given intranasally, as well as an IV version of psilocybin, as potential treatments for depression. Both are designed to have short-acting effects, with the peak experience lasting just 10 to 15 minutes. In the Lykos trials, MDMA sessions lasted eight hours.

    “What we offer during the therapeutic session is support, there’s no psychotherapy,” says Rob Conley, Beckley Psytech’s chief scientific and medical officer. “From a safety standpoint, we think short is good.”

    Whether Lykos will stick with its plans to pursue MDMA-assisted therapy, or pursue approval or just MDMA, remains to be seen. Either way, the company said it remains “deeply dedicated” to bringing MDMA to those suffering from PTSD.

    [ad_2]

    Emily Mullin

    Source link

  • This Code Breaker Is Using AI to Decode the Heart’s Secret Rhythms

    This Code Breaker Is Using AI to Decode the Heart’s Secret Rhythms

    [ad_1]

    Roeland Decorte grew up in a nursing home in Belgium, where he learned to spot the subtle early signs of mental decline in small changes to how residents walked or talked. When Decorte was 11, his father, who owned and managed the care home, started waking up in the middle of the night with chest pains and an overwhelming sense of impending doom.

    He went to two doctors, who briefly listened to his heartbeat through their stethoscopes and diagnosed him with anxiety. But the symptoms persisted, and it was only when he underwent a full set of scans at a private hospital that a third doctor uncovered the source of the problem—a tiny hole between the left and right chambers of his heart. If left unnoticed, it would have killed him—he was 39.

    Disaster averted, the young Decorte was able to focus on his studies, and by age 17 he was an undergraduate at the University of Cambridge—the youngest Belgian ever to attend the prestigious college. (This caused some logistical issues: His tutor had to become his legal guardian, and a new payment system had to be put in place at the college bar to prevent him from buying alcohol like his peers.)

    He spent the next seven years specializing in ancient codebreaking, and a comfy career in academia (or a more exciting one as an Indiana Jones–style relic hunter) beckoned. But Decorte never stopped thinking about what had happened to his dad and how he could have been diagnosed much sooner if a doctor, any doctor, had spent more than 30 seconds listening to his heart. So in 2019, lacking medical training but armed with the confidence that only an Oxbridge education can provide, the then 27-year-old Decorte founded a company and turned his attention to cracking a different ancient code: the secret rhythm of the heart.

    There’s an AI boom in health care, and the only thing slowing it down is a lack of data. Meanwhile, time-pressured doctors can collect information only sporadically. Wearables such as smartwatches might be able to measure pulse, but they’re bad at more specific diagnoses (partly because the wrist is about as far away from the really vital organs as you can get).

    Decorte wanted to develop a piece of technology that could monitor the body continuously and precisely, so that people like his father could get the treatment they need more quickly. He began by trying to build sensors into clothes so people could track their vitals without a doctor’s visit. Then he designed an elaborate exoskeleton packed with sensors to measure all kinds of ailments. This attracted some military interest but wouldn’t really have helped someone like Decorte’s father. “I was very naive,” he said when we met recently in the wood-paneled basement of a twee café in Mayfair, London. “There was about two years full-time where I was just working out of the spare room in my house doing nothing else.” But the problem he kept running into was noise: Unless you could build a contraption that pressed each sensor right against the skin, there was too much random interference from people moving around in the world to get a good sense of what was actually happening in the body.

    [ad_2]

    Amit Katwala

    Source link

  • Women’s hockey tournament benefits cancer survivors

    Women’s hockey tournament benefits cancer survivors

    [ad_1]

    HAVERHILL — More than 500 women will hit the ice this weekend with a goal of raising money for cancer survivorship services in the Merrimack Valley.

    The annual Cross Check Cancer Women’s Hockey Tournament will take place from Aug. 9 to 11 at the Valley Forums in Haverhill and Lawrence. The cancer survivorship program is designed to help adults transition to a post-cancer life.

    Games will also be played at HockeyTown U.S.A .in Saugus.

    The women’s tournament was founded by Keri Capobianco in 2016. Capobianco started and runs the Women’s Hockey League of Boston, which calls Haverhill, Methuen and Peabody rinks home. The league is a place where women ages 18 to 60-plus of different skill levels can play hockey.

    The tournament is open to all women, who travel from all over New England to participate.

    All proceeds benefit Dana-Farber Cancer Institute’s Adult Survivorship Program, which offers those 21 years old and older access to services that help adult patients find expertise, education and any support they may need.

    Women who’ve survived cancer or are in treatment have participated in the event over the years, Capobianco said.

    She was drawn to supporting the Dana-Farber program because it’s designed to help people get back to their passions after cancer, whether that’s hockey or another activity. It also places an emphasis on nutrition, exercise and women’s health issues.

    The tournament’s creation was led by a grassroots effort by Capobianco and women from the WHL of Boston eight years ago. In 2016, they were happy to raise $5,200, Capobianco said.

    Now, there are 40 teams signed up for the three-day event and funds raised have grown each year since that first tournament. In 2023, the teams raised more than $65,000. To date, they’ve been able to donate $179,000 to the survivorship program.

    “It’s grown dramatically,” Capobianco said.

    “You don’t see that often where 100% of the proceeds goes to Dana Farber,” tournament participant Christine Ray said. “It’s amazing what Keri (Capobianco) has been able to do with this tournament, especially managing 40 teams at three different rinks.”

    Ray, 59, of Bolton, is one of the many women who travels each year to play in the tournament. She’s played in all eight tournaments so far and her team is ready for the next one.

    Ray first learned to skate at age 43 and has been hooked on hockey ever since. But the summer games mean more than lacing up the skates to her.

    “It’s so much more than hockey,” Ray said. “It gives women a chance to get together and reconnect and do some good at the same time.”

    Ray has known Capobianco for several years by playing hockey with her. Ray formed a tournament team in 2016 to support her friend and has watched as the fundraiser grew to hundreds of women bonding over their passion for the sport as a way to help the cancer community.

    “It’s supporting cancer survivors and being able to play hockey and doing something healthy for ourselves at the same time,” Ray said.

    The goal is to surpass last year’s fundraiser and cross the overall $250,000 mark in its ninth year.

    “We’re always trying to outdo ourselves,” Capobianco said. “We want to hit $70,000 this year.”

    The three rinks are sure to be busy as games are set from 9 a.m. to 10 p.m., but Capobianco said she wouldn’t have it any other way.

    The busyness means women are getting involved and doing their part to continue to benefit the mission of the tournament – cross check cancer.

    “Now we are able to connect these women who share the same passion for hockey and do some good in the world at the same time,” Capobianco said. “It’s a fantastic feeling.”

    [ad_2]

    By Angelina Berube | aberube@eagletribune.com

    Source link

  • Experimental Biology and Medicine Conference 2024: A Premier Interdisciplinary Event for Biomedical Research

    Experimental Biology and Medicine Conference 2024: A Premier Interdisciplinary Event for Biomedical Research

    [ad_1]

    The Society for Experimental Biology and Medicine (SEBM) is proud to announce its upcoming Experimental Biology and Medicine Conference (EBMC), to be held from October 13th to 16th, 2024, at the Embassy Suites by Hilton Orlando Lake Buena Vista South, in the vibrant city of Orlando. As one of the oldest biomedical research societies, established in 1903, SEBM continues its legacy of fostering collaboration and innovation among scientists across various disciplines.

    EBMC will serve as a vital platform for experimental biology scientists from diverse backgrounds to converge, network, and exchange cutting-edge research findings. With a rich history spanning over a century, SEBM and its renowned journal, Experimental Biology and Medicine, remain steadfast in their commitment to advancing basic, translational, and clinical research.

    This year, EBMC is honored to welcome Dr. Michael Friedlander, Ph.D., Vice President for Health Sciences and Technology and Senior Dean for Research at Virginia Tech School of Medicine, as the keynote speaker. Dr. Friedlander’s expertise and insights promise to enrich the conference experience, inspiring attendees to delve deeper into the realms of this incredible industry.

    EBMC warmly welcomes attendees and late-breaking abstract submissions covering a wide spectrum of research topics. Interested individuals can explore journal categories on the SEBM website, and discover opportunities to contribute to the advancement of biomedical science.

    For further details and registration, please visit ExBioMedCon.org.

    About SEBM

    SEBM’s mission is to promote investigation in the biomedical sciences mainly through the publication of a peer-reviewed journal, Experimental Biology and Medicine, and to foster the career development of students, physician-scientists and new investigators. Founded in 1903, the Society for Experimental Biology and Medicine (SEBM) is a not-for-profit scientific society formed to promote investigation in the biomedical sciences by encouraging and facilitating the interchange of scientific information among disciplines. The principal means for achieving this purpose are the publication of a peer-reviewed journal, Experimental Biology and Medicine, and support of regional and national meetings. The Society also fosters the career development of students and new investigators. SEBM has nearly 1,000 members worldwide, the majority of whom have their doctoral degrees and are actively engaged in various fields of biomedical research. Membership dues include discounts to Society events and author publishing charges for our journal, Experimental Biology and Medicine.

    Contact Information:

    Events, Media, Sponsorships

    Emily Hartstone

    Email: emily@sebm.org

    For interview requests, please contact Jessica Homa at jhoma@sebm.org.

    Source: Society for Experimental Biology and Medicine

    [ad_2]

    Source link

  • Local hospital network data breach may affect over 500

    Local hospital network data breach may affect over 500

    [ad_1]

    SALEM, N.H. — A data breach at a local hospital network caused more than 500 patients’ personal information to be leaked.

    Northeast Rehabilitation Hospital Network, 70 Butler St., announced on its website that between May 13 and May 22, there was unauthorized access to the company’s network and files containing sensitive information may have been accessed.

    Information was accessed from Neuro Rehab Associates Inc., a subsidiary founded in 1983, according to the data breach portal for the U.S. Department of Health and Human Services’ Office for Civil Rights.

    The breach was reported to the Department of Health and Human Services on July 17.

    Despite claiming it was an instance of unauthorized access, the department categorized the breach as a hacking and IT incident and noted the information was found on network servers.

    NRHN said it is investigating the breach’s severity and will only notify people who have been affected and that it reported the incident to a federal law enforcement agency.

    NRHN has four inpatient hospitals in New Hampshire and more than 25 outpatient rehabilitation clinics across Massachusetts and New Hampshire.

    The company said while it is still investigating the breach’s extent, the information that could have been stolen includes patients’ names, contact information, dates of birth, Social Security numbers, driver’s license and ID numbers, financial account information, diagnoses, treatments and health insurance information.

    NRHN has asked for patients to remain vigilant and, if they believe they are a victim of this breach, to contact it by email at NRHNCyberInfo@northeastrehab.com.

    [ad_2]

    By Katelyn Sahagian | ksahagian@northofboston.com

    Source link

  • Simone Biles’ triumphant Olympics comeback is a testament to something quite ordinary: consistent therapy

    Simone Biles’ triumphant Olympics comeback is a testament to something quite ordinary: consistent therapy

    [ad_1]

    Simone Biles wouldn’t be on the mat if she didn’t spend time on the couch, she explained at this year’s Olympics in Paris. 

    As the most decorated gymnast in history, Biles knows keenly what it’s like to have an immense amount of pressure on her. She’s had the world’s gimlet-eyed gaze on her multiple times, after all. Biles came to this summer’s Olympics already setting records, currently holding the title as the oldest women’s gymnast to compete since the 1950s. While this isn’t Biles’ first rodeo, she’s making sure to play the high-stakes game a little differently this time around— on her terms.

    “Being in a good mental spot, seeing my therapist every Thursday is kind of religious for me. So that’s why I’m kind of here today,” Biles said late last month after making the Olympic team. 

    The iconic gymnast made strides after the last Olympics, making a concerted effort not just to work on her mental health, but also to share insight about her journey publically to assuage stigma. She has also come forward as a survivor of sexual abuse of disgraced former national gymnastics team doctor Larry Nassar, explaining “it could help a lot of people. Four years ago, Biles made headlines after dropping out of the 2020 Summer Olympics in Tokyo due to what is called the “the twisties.”

    The ailment is known as a disconnect between the brain and body which makes gymnasts disoriented. Biles’ candor regarding the toll that this condition took and her decision to leave catapulted her into a new type of spotlight: that of a mental-health advocate. 

    “We also have to focus on ourselves, because at the end of the day we’re human, too,” she said after leaving the competition. “So, we have to protect our mind and our body, rather than just go out there and do what the world wants us to do.” 

    Not only is Biles stepping into the arena with a newfound dedication to her well-being, she’s also making sure to look after her teammates. Biles provided advice to fellow gymnast Suni Lee after she struggled during her routine. Having gone through the exact same situation, Biles said she knew Lee needed support. She explained that’s exactly what she gave her, adding “ I know how traumatizing it is, especially on a big stage like this. I didn’t want her to get in her head.”

    Her newly released Netflix documentary, Simone Biles Rising, further pushes back the curtain behind the trying experience that is competing on a national stage. Giving context to her re-emergence in the Olympics, Biles opened up about her process in going to therapy and dealing with past trauma. 

    Showing the screen her tattoo of Maya Angelou’s words, Biles says she’s not backing down from what she’s gone through. Rather, she’s letting it fuel her. “‘And still I rise’ is perfect,” she adds. “I feel like that’s kind of the epitome of my career and life story. I always rise to the occasion; even after all of the traumas and the downfalls, I’ve always risen.”

    [ad_2]

    Chloe Berger

    Source link

  • Salem Pantry and Mass General Brigham partner to offer free walk-in clinics

    Salem Pantry and Mass General Brigham partner to offer free walk-in clinics

    [ad_1]

    The Salem Pantry and Mass General Brigham announced they will be continuing their partnership to bring their “Community Care Van” weekly free health service to the Pantry’s The Market location at 47 Leavitt St. in Salem.

    In an effort to increase access to essential health care services for residents of Salem and neighboring communities, the van serves as a sort of mobile doctor’s office to provide individuals with medical services like blood pressure screenings, diabetes screenings and care, health education, and care kits. No appointment is needed, and the hospital staffers will not ask about immigration status.

    “Our work with Mass General Brigham is an important part of our commitment to creating an overall healthier community,” said Director of Programs and Partnerships Mike Lilley. “It allows us to address both the immediate need for food and the long-term health needs of our neighbors.”

    “Community Care vans extend the front door of our hospital into the neighborhoods we serve, providing place-based care. Our efforts aim not only to deliver clinical care but also to address social risks, such as food insecurity, which significantly impact health. Community partnerships like these at food pantries are essential to the care we strive to deliver,” said Priya Sarin Gupta, MD MPH, medical director, Clinical Community Programs at Mass General Brigham.

    The Salem Pantry, Mass General Brigham, and the Salem Hospital also offer a weekly mobile food pantry at the North Shore Physicians Group Salem location. Mass General Brigham, which has remained a key financial supporter of the Salem Pantry since 2022, has also helped to develop the pantry’s Food is Medicine program and nutritional services to combat food insecurity locally.

    The Market currently hosts an average of 1,350 weekly visits from residents of Salem and surrounding areas, including Lynn, Peabody, and Beverly. The addition of the Community Care Van at this location is hoped to further support the health and well-being of these communities.

    For more information about The Salem Pantry’s services and walk-in clinic hours, visit thesalempantry.org.

    Michael McHugh can be contacted at mmchugh@northofboston.com or at 781-799-5202

    [ad_2]

    By Michael McHugh | Staff Writer

    Source link

  • It’s Shockingly Easy to Buy Off-Brand Ozempic Online, Even if You Don’t Need It

    It’s Shockingly Easy to Buy Off-Brand Ozempic Online, Even if You Don’t Need It

    [ad_1]

    Eli Lilly and Novo Nordisk have both recently taken legal action against companies selling compounded versions of drugs, often alleging trademark infringement. Novo Nordisk has filed 21 lawsuits since last summer. This June, Eli Lilly initiated six lawsuits, following 10 other lawsuits that the pharmaceutical company began last fall. In one, filed against a company selling compounded GLP-1s online, it alleged that passing compounded drugs off as having identical active ingredients as its products was “not merely deceptive—it’s dangerous.”

    “Telehealth providers and compounding pharmacies that are claiming to offer or sell unapproved compounded products claiming to contain ‘semaglutide’ are sourcing their ingredients from entities other than Novo Nordisk,” Novo Nordisk spokesperson Jamie Bennett told WIRED. “As the FDA has cautioned, unapproved compounded ‘semaglutide’ drugs do not have the same safety, quality, and effectiveness assurances as Novo Nordisk’s FDA-approved semaglutide medicines, and patients should not use a compounded drug if an approved drug is available.”

    “There’s huge safety implications,” Ryder says. In 2012, a compounding pharmacy caused a fungal meningitis outbreak that killed at least 64 people, among the worst pharmaceutical drug-contamination disasters in the United States. The supervisory pharmacist who oversaw the manufacture of this medicine was sentenced to prison time, and the event led to tightened oversight and licensing requirements for compounders.

    Some of the leading compounding pharmacies that produce GLP-1 medications have landed in trouble for their practices. Hallandale Pharmacy, a popular supplier—two of my four vials came in its sleek blue packaging—has run into trouble with regulators for past infractions, which included concerns over record-keeping and facility conditions. It has received warning letters from the FDA, although the last one was closed out in May 2022, which means the FDA found that it had addressed outstanding issues. (Hallandale declined requests for comment.)

    The FDA has found issues with pharmaceutical companies, too, though. In 2023, FDA inspectors found bacterial contamination at a Novo Nordisk production plant in North Carolina. “Leadership addressed immediately, and the site received FDA approval for full production for market in August 2023,” Novo Nordisk’s Bennett says.

    Compounding advocates say that, although the drugs are not FDA-approved, they are still subject to rigorous quality control, in part due to post-2012 rule changes. Carroll, for example, says Hims did “due diligence” when choosing its pharmacy and that it has been satisfied with the medication quality. “We’ve seen an extremely good response from our customers,” he says. “No untoward side effects that we didn’t anticipate.” According to Carroll, Hims has not had to report any adverse effects to the FDA.

    What’s Next?

    As researchers continue to discover new potential use cases for GLP-1 drugs, and public interest and demand remains high, these drugs may be on the FDA’s official shortage list for months or even years to come. If the shortage ends, one type of compounding pharmacy (called 503a) would be required to stop production immediately, while 503b pharmacies, which typically produce on a larger scale, would have 60 days. An end to the shortage would require some substantial pivots within this booming cottage industry. None of the telehealth companies that sent compounded semaglutide to WIRED made mention of what might happen in this scenario during the intake process.

    Many people who take compounded drugs may be taken by surprise if they are told they must switch to brand names—and pay much higher prices—within a matter of months.

    However, even when the shortage does officially end, at least some of the telehealth companies do not plan to pivot from compounding. “We believe there’s going to be more and more demand for the medication, so that may actually prolong the shortage list,” says Hims’ Pat Caroll. “We are convinced there’s a pathway, even when it comes off the shortage list, to supply these compounded medications.”

    Even compounding skeptics suspect that it’s not going away anytime soon. With demand so high, Ryder suspects pharmaceutical companies will need to ramp up production to serve “basically 40 percent of the US population” before shortages end. Until then, Ryder suspects this telehealth boom will continue unabated.

    For now, the vials of compounded semaglutide WIRED ordered are sitting in the back of a fridge untouched.

    [ad_2]

    Kate Knibbs

    Source link

  • Sexist Myths Are a Danger to Health

    Sexist Myths Are a Danger to Health

    [ad_1]

    In 2013, the US Food and Drug Administration made an unprecedented recommendation, advising that women should receive a lower dosage of the insomnia drug zolpidem than men. The rationale behind it was that medication seemed to affect women for longer periods, which could become a safety issue.

    However, in 2019, research conducted at Tufts University concluded that the differential effect of the medication had nothing to do with sex. Rather, researchers found that what determined the rate at which the person cleared the drug from their system was their body size. The report concluded that the reduced prescribed dosage for women could in fact lead to underdosing and a failure to effectively treat insomnia. “They were using sex as a proxy for body size because we tend to collect data about sex; we don’t collect data about body size,” says Angela Saini, author of The Patriarchs: How Men Came to Rule. “This is the perverse way that sometimes medicine works: You base your diagnostics on the data you have rather than the data you need.”

    Indeed, Saini argues that many of the prevailing gaps in health outcomes between men and women have nothing to do with biological sex. “It can be so tempting for scientists to look at a gap and want to find a simple biological explanation for it, but when it comes to gender and health those simple explanations often don’t exist,” she said.

    Of course, sex differences do exist in aspects of health, such as reproductive health and physiology. However, what research suggests is that, in most cases, the health-related difference between men and women—from disease symptoms to drug efficacy—is really quite marginal. “The differences that do exist are down to gender,” Saini says. “Differences in the way people are treated and thought about and the assumptions we make about them.” That, according to Saini, is what explains many of the failures when it comes to women’s health.

    Consider, for instance, the common misconception that women present atypical heart-attack symptoms, different from men’s. This prevailing myth was quashed by a 2019 study, funded by the British Heart Foundation, at the University of Edinburgh. The research, which involved nearly 2,000 patients, showed that, in fact, 93 percent of both sexes reported chest pain—the most common symptom—while a similar percentage of men and women (nearly 50 percent) also felt pain radiating from their left arm. “The problem of underdiagnosis of women is because health professionals and even the women themselves who are having a heart attack believe heart attacks are something that mostly happens to men,” Saini says. Estimates indicate that differences in care for women have led to approximately 8,200 avoidable deaths due to heart attacks in England and Wales since 2014.

    “It’s not about men discriminating against women; this is often about women not being listened to—sometimes by other women,” she says. Another example that starkly illustrates how gender can affect health outcomes came from a 2016 Canadian study about patients who had been hospitalized with acute coronary syndrome. The research showed that the patients who experienced higher rates of recurrence were the ones who performed gender roles stereotypically associated with women—like doing more housework and not being the primary earner at home—independently of whether they were a man or a woman. “This was because people who carried out a female social role were more likely to be anxious.” Saini says.

    If these disparities are caused by the way patients are perceived and treated, the solution, to Saini, is clear: “We need to be careful to diagnose the problem where it is, not where we imagine it to be.” She highlights the successful work of Jennie Joseph, a British midwife who, in 2009, founded the Commonsense Childbirth School of Midwifery in Orlando, Florida, to support women without access to maternal health care. Research has shown that Black mothers, both in the US and in the UK, are three times more likely to die than white women.

    “Joseph lowered maternal mortality rates among minority women simply by improving the quality of their care, listening to their concerns, and responding when they say they’re in pain,” Saini says. “We don’t need technology to solve this issue. We just very simply can’t allow our biases and prejudices to get in the way.”

    This article appears in the July/August 2024 issue of WIRED UK magazine.

    [ad_2]

    João Medeiros

    Source link

  • Opioid deaths drop 10%, but remain high

    Opioid deaths drop 10%, but remain high

    [ad_1]

    BOSTON — The scourge of opioid addiction continues to affect Massachusetts, but new data shows a double-digit decrease in the number of overdose deaths in the past year.

    There were 2,125 confirmed or suspected opioid-related deaths in 2023 — which is 10%, or 232, fewer fatal overdoses than during the same period in 2022, according to a report released this week by the state Department of Public Health.

    Last year’s opioid-related overdose death rate also decreased by 10% to 30.2 per 100,000 people compared to 33.5 in 2022, DPH said.

    Health officials attributed the persistently high death rates to the effects of an “increasingly poisoned drug supply,” primarily with the powerful synthetic opioid fentanyl.

    Fentanyl was present in 90% of the overdose deaths where a toxicology report was available, state officials noted.

    Preliminary data from the first three months of 2024 showed a continued decline in opioid-related overdose deaths, the agency said, with 507 confirmed and estimated deaths, a 9% drop from the same time period last year.

    Gov. Maura Healey said she is “encouraged” by the drop in fatal overdoses but the state needs to continue to focus on “prevention, treatment and recovery efforts to address the overdose crisis that continues to claim too many lives and devastate too many families in Massachusetts.”

    Substance abuse counselors welcomed the declining number of fatal opioid overdoses, but said the data shows that there is still more work to be done to help people struggling with substance use disorders.

    “While the number of opioid-related overdose deaths in the commonwealth remains unacceptably high, it is encouraging to see what we hope is a reversal of a long and painful trend,” Bridgewell President & CEO Chris Tuttle said in a statement. “The time is now to boost public investments and once and for all overcome the scourge of the opioid epidemic.”

    Nationally, there were 107,543 overdose deaths reported in the U.S. in 2023, a 3% decrease from the estimated 111,029 in 2022, according to recently released U.S. Centers for Disease Control and Prevention data.

    In New Hampshire, drug overdose deaths also declined by double digits in 2023, according to figures released in May by the state’s medical examiner and the National Centers for Disease Control.

    There were 430 deaths attributed to overdoses in 2023, an 11.7% decrease from 2022’s 487, according to the data.

    Curbing opioid addiction has been a major focus on Beacon Hill for a number of years with hundreds of millions of dollars being devoted to expanding treatment and prevention efforts.

    The state has set some of the strictest opioid-prescribing laws in the nation, including a cap on new prescriptions in a seven-day period and a requirement that doctors consult a state prescription monitoring database before prescribing an addictive opioid.

    Hundreds of millions of dollars are flowing into the state from multistate settlements with opioid makers and distributors, including $110 million from a $6 billion deal with OxyContin maker Purdue Pharma and the Sackler family.

    Under state law, about 60% of that money will be deposited in the state’s opioid recovery fund, while the remainder will be distributed to communities.

    Earlier this week, House lawmakers were expected to take up a package of bills aimed at improving treatment of substance abuse disorders and reducing opioid overdose deaths.

    The plan would require private insurers to cover emergency opioid overdose-reversing drugs such as naloxone and require drug treatment facilities to provide two doses of overdose-reversal drugs when discharging patients, among other changes.

    Another provision would require licenses for recovery coaches, who are increasingly sent to emergency rooms, drug treatment centers and courtrooms to help addicts get clean.

    Backers of the plan said the goal is to integrate peer recovery coaches more into the state’s health care system, helping addicts who have taken the first steps toward recovery.

    Long-term recovery remains one of the biggest hurdles to breaking the cycle of addiction, they say.

    Christian M. Wade covers the Massachusetts Statehouse for North of Boston Media Group’s newspapers and websites. Email him at cwade@cnhinews.com.

    [ad_2]

    By Christian M. Wade | Statehouse Reporter

    Source link

  • Healthy Life Checklist (PDF)

    Healthy Life Checklist (PDF)

    [ad_1]

    A comprehensive health checklist covering all aspects of a healthy and balanced life, including hygiene, exercise, diet, sleep, and more! Discover essential wellness activities to incorporate daily, weekly, monthly, and annually.


    This content is for Monthly, Yearly, and Lifetime members only.
    Join Here Login

    [ad_2]

    Steven Handel

    Source link

  • WTF Fun Fact 13749 – Worm Therapy

    WTF Fun Fact 13749 – Worm Therapy

    [ad_1]

    What would make you agree to worm therapy? When you hear what they can do, you might be more interested than you could have imagined.

    Imagine curing severe allergies or autoimmune diseases not with advanced biotech drugs but with worms? Yes, the creepy crawlies might just be the unexpected heroes in the saga of human health, specifically gut-dwelling parasites like hookworms.

    Hookworms: The Gut’s Unlikely Allies

    In a twist that might make even the bravest squirm, recent research explores using parasitic worms as a potential treatment for autoimmune diseases. This idea stems from an intriguing theory: these parasites, by damping down our immune systems, might stop it from attacking our own bodies—an overreaction that’s a hallmark of autoimmune issues.

    Science writer Moises Velasquez-Manoff, inspired by personal health challenges including alopecia and hay fever, ventured into this uncharted territory. His journey led him to Tijuana, where he intentionally infected himself with 30 hookworms. Yes, you read that right—Velasquez-Manoff allowed nearly three dozen parasites to take up residence in his intestines.

    A Microscopic Invasion with Macro Implications

    Hookworm larvae start their invasion by burrowing into the skin. They journey through the bloodstream to the lungs, then migrate to the small intestine where they clamp onto the intestinal walls and start feeding on the host’s blood. While this sounds like something out of a horror film, the real shocker comes from what happens next.

    Once settled in the gut, these worms perform a bit of immunological magic. They suppress the immune system just enough to avoid being attacked by it. Researchers like P’ng Loke from the New York University School of Medicine suggest that this could prevent the immune system from overreacting. In theory, this should help alleviate symptoms of autoimmune diseases.

    The Clinical Trial Turbulence

    Excited by the potential, a pharmaceutical company, Coronado Biosciences, launched clinical trials to test this theory. They explored whether pig whipworms could help patients with Crohn’s disease. However, the results were disappointing. The trials showed that the patients who received the worm treatment did no better than those who took a placebo. Consequently, Coronado Biosciences saw its stock value crash and eventually shifted its business focus after canceling further trials.

    Despite the setbacks in clinical trials, the concept of using parasitic worms for treating autoimmune diseases isn’t dead. The mixed results hint at a complex relationship between humans and parasites, possibly influenced by genetic factors or the specific conditions of the trials.

    Velasquez-Manoff’s Personal Experiment

    Back to our adventurous science writer—Velasquez-Manoff noticed significant temporary relief from his hay fever post-infestation. He even saw signs of hair growth, although minor. Unfortunately, the positive effects didn’t last. His symptoms returned, and the side effects of hosting the worms—like diarrhea and cramps—made the whole ordeal quite unpleasant.

    Worm Therapy: A Gutsy Move?

    Velasquez-Manoff’s personal conclusion was clear: the discomfort and risks of worm therapy did not outweigh its transient benefits. His experience underscores the complexity of biohacking with parasites. What works as a theoretical treatment might not translate into a practical or comfortable solution.

    The Future of Worm Therapy

    The journey of using parasites as a treatment is still in its infancy. While some may hold onto hope for worm-based therapies, current evidence suggests a cautious approach. Future research needs to address the variability in treatment outcomes and the potential long-term effects of such therapies.

    In the meantime, those suffering from allergies or autoimmune diseases might want to stick to more conventional treatments. And as for the rest of us, perhaps it’s best to keep the worms in the garden, and out of our guts, at least for now.

     WTF fun facts

    Source: “Could Worms In Your Gut Cure Your Allergies?” — NPR

    [ad_2]

    WTF

    Source link

  • Woman Who Received Pig Kidney Transplant Has It Removed

    Woman Who Received Pig Kidney Transplant Has It Removed

    [ad_1]

    Surgeons in New York have removed a pig kidney less than two months after transplanting it into Lisa Pisano, a 54-year-old woman with kidney failure who also needed a mechanical heart pump. The team behind the transplant says there were problems with the heart pump, not the pig kidney, and that the patient is in stable condition.

    Pisano was facing heart and kidney failure and required routine dialysis. She wasn’t eligible to receive a traditional heart and kidney transplant from a human donor because of several chronic medical conditions that reduced the likelihood of a good outcome.

    Pisano first received a heart pump at NYU Langone Health on April 4, followed by the pig kidney transplant on April 12. The heart pump, a device called a left ventricular assist device or LVAD, is used in patients who are either awaiting heart transplantation or otherwise aren’t a candidate for a heart transplant.

    In a statement provided to WIRED, Pisano’s medical team explained that they electively removed the pig kidney on May 29—47 days after transplant—after several episodes of the heart pump not being able to pass enough blood through the transplanted kidney. Steady blood flow is important so that the kidney can produce urine and filter waste. Without it, Pisano’s kidney function began to decline.

    “On balance, the kidney was no longer contributing enough to justify continuing the immunosuppression regimen,” said Robert Montgomery, director of the NYU Langone Transplant Institute, in the statement. Like traditional transplant patients, Pisano needed to take immunosuppressive drugs to prevent her immune system from rejecting the donor organ.

    The kidney came from a pig genetically engineered by Virginia biotech company Revivicor to lack a gene responsible for the production of a sugar known as alpha-gal. In previous studies at NYU Langone, researchers found that removing this sugar prevented immediate rejection of the organ when transplanted into brain-dead patients. During Pisano’s surgery, the donor pig’s thymus gland, which is responsible for “educating” the immune system, was also transplanted to reduce the likelihood of rejection.

    A recent biopsy did not show signs of rejection, but Pisano’s kidney was injured due to a lack of blood flow, according to the statement. The team plans to study the explanted pig kidney to learn more.

    Pisano is now back on dialysis, a treatment for kidney-failure patients, and her heart pump is still functioning. She would not have been a candidate for the heart pump if she had not received the pig kidney.

    “We are hoping to get Lisa back home to her family soon,” Montgomery said, calling Pisano a “pioneer and a hero in the effort to create a sustainable option for people waiting for an organ transplant.”

    Pisano was the second living person to receive a kidney from a genetically engineered pig. The first, Richard Slayman of Massachusetts, died in May just two months after the historic transplant. The surgery was carried out on March 16 at Massachusetts General Hospital. In a statement released on May 11, the hospital said it had “no indication” that Slayman’s death was the result of the pig kidney transplant. The donor pig used in Slayman’s procedure had a total of 69 different genetic edits.

    The global donor organ shortage has led researchers including the NYU and Massachusetts teams to pursue the possibility of using pigs as an alternative source. But the body immediately recognizes pig tissue as foreign, so scientists are using gene editing in an effort to make pig organs look more like human ones to the immune system. Just how many gene edits will be needed to keep pig organs working in people is a topic of much debate.

    Pig heart transplants have also been carried out in two individuals—one in 2022 and the other in 2023—at the University of Maryland. In both cases, the patients were not eligible for human ones. Those donor pigs had 10 genetic edits and were also bred by Revivcor. Both recipients died around two months after their transplants.

    [ad_2]

    Emily Mullin

    Source link

  • Easy low-carb meals to break habits and build rituals

    Easy low-carb meals to break habits and build rituals

    [ad_1]

    Have you been feeling a little bit off lately? If you’re experiencing energy crashes, constant hunger and acne breakouts, a low-carb lifestyle may be what you need. Explore what it means to transition to low-carb living, including tips on easy recipes and practical steps you need to take to make this happen.

    The shift towards low-carb living

    With all the talk about low-carb food, you’re probably wondering what all this buzz is about. The discussion has recently grown because people are experiencing the consequences of poor eating habits and are turning to low-carb diets to reclaim their health.

    The science behind it

    This lifestyle has gained popularity for its potential to help manage weight and control blood sugar levels. When you consume fewer carbs, you lower your insulin levels, which studies in the HHS Public Access journal have shown is effective in weight loss.

    Another factor is that if you eat less carbs, you’ll most likely make up for it by increasing the amount of fat and protein in your diet. This helps you feel full for longer and consume fewer calories. Due to these health claims, a wide variety of people are trying to go low-carb — from athletes to those wanting to lose weight or manage their diabetes.

    Take precautions

    Despite these potential benefits, a low-carb diet should be done with precaution. There are side effects if you overdo it — overeating protein can worsen kidney function, increase cholesterol and cause constipation. Please consult with a healthcare professional before making any major changes to your diet, especially if you have pre-existing health concerns.

    Practical steps for transitioning to a low-carb lifestyle

    If you want to start a healthier lifestyle, integrate small changes rather than a complete overhaul. That way, you’ll be more likely to stick with these new habits.

    Do your research

    First, it’s important to understand that not all low-carbs are good for you. Simple carbs like white sugar or flour spike your blood sugar, making you hungry faster. You avoid that with complex carbs found in more nutritious food like whole grains, as it takes longer for these types of carbs to digest.

    That’s why that cookie or beer on paper may seem like it fits within the diet’s parameters, but to improve your health, you should focus on whole food. Fresh vegetables and lean meats will become your best friend.

    Easy low-carb meals

    With that in mind, start making substitutions around your kitchen. Replace white rice with finely chopped cauliflower for a meal or two. Sprinkle in some chia seeds in your yogurt bowl. Switch your seed oil with olive oil. These substitutions may seem small, but they establish healthy eating habits that change a low-carb diet from a fad to a sustainable lifestyle.

    Listen to your body

    A big part of transitioning to a low-carb lifestyle is personalizing it to your body. Explore what feels right and what doesn’t. For example, you may like the keto diet — a more restrictive low-carb diet that limits carbs to 20 to 50 grams daily. Here, your focus will be on consuming high-fat, moderate-protein and low-carb foods. With that criteria, you’re probably wondering if anything meets those standards, but you can still enjoy foods like Greek yogurt, fish, eggs, cottage cheese and meat.

    There are also plenty of keto-friendly recipes that can replace staples like bread. Try making this farmers bread that is low-carb, gluten-free and diabetic-friendly. The secret ingredient is potato fiber flour. It tastes like real bread but with extra fiber and minimal carbs. Exploring these alternatives helps to break carb-centric eating habits and replace them with healthy low-carb food.

    Shift in social activities

    A lot of social activities revolve around eating carb-heavy foods, like going for drinks and pub food. This can get expensive and unhealthy, especially if you’re eating out multiple times a week. Consider shifting some social activities beyond just meals. Explore new hiking trails, try out dance classes or even pottery lessons. With these hobbies, you don’t have to resort to restaurants every time you want to catch up with a friend.

    Incorporating low-carb living into daily routines

    Picking up routines like meal prepping and regular exercise helps support a low-carb lifestyle. These rituals make sure that you continue to prioritize your health and well-being in the long term.

    Meal prep

    Meal planning helps you stay on track to avoid the temptation to order takeout. Stocking up a low-carb pantry ensures you have everything on hand for your meals. Keto or low-carb flour and pasta are essentials, as well as milk substitutes like almond or coconut milk. Consider having healthy snacks, too, for when you feel like munching on something before your next meal.

    Thai tofu collard wraps are a fun meal to make ahead of time for a fresh and delicious lunch. Just blanch collard leaves and fill them up with tofu, cucumber, carrot and Thai basil. Make some peanut sauce on the side for the perfect dip.

    Active lifestyle

    Getting more active doesn’t have to be as intimidating as signing up for a gym membership. It can look like going on walks after a meal or doing light yoga stretches in the morning. Make it a social activity and gather your friends or coworkers for a volleyball intramural. Find whatever is enjoyable for you.

    Why low-carb living matters beyond weight loss

    The benefits of this lifestyle extend beyond how it affects the scale. According to StatsPearls, adopting a low-carb diet can help reduce energy crashes by replacing simple carbs with healthy fats and protein. With more consistent energy levels throughout the day, you’ll be less prone to taking those afternoon naps that ruin the flow of your day.

    Studies in StatsPearls have also shown that keto diets can help manage acne, polycystic ovary syndrome — commonly known as PCOS — and Alzheimer’s.

    Although there are studies that show the short-term benefits of keto diets, there has been limited research on their long-term effects. This emphasizes the need to be mindful of how you approach this lifestyle, as its restrictive nature may not be for everyone.

    Breaking free from carb-centric habits

    A low-carb lifestyle can give you the opportunity to reclaim your health if you do it right. There are plenty of delicious low-carb meals that make healthy eating easy and sustainable. Try out this lifestyle for yourself by starting with small habits that will ensure success in the long run.

    Zuzana Paar is the creative force behind her websites Low Carb No Carb, and Best Clean Eating.

    [ad_2]

    By Zuzana Paar | Food Drink Life

    Source link

  • Few prepared to cover long-term care costs

    Few prepared to cover long-term care costs

    [ad_1]

    Editor’s note: The share of the U.S. population older than 65 keeps rising – and will for decades to come. Since nearly half of Americans over 65 will pay for some version of long-term health care, CNHI News and The Associated Press examined the state of long-term care in the series High Cost of Long-Term Care, which began Friday and continues this week.

    While many Americans will need long-term care as they get older, few are prepared to pay for it.

    Medicare, which provides Americans over the age 65 with health insurance, doesn’t cover most long-term care services. And Medicaid — the primary safety net for long-term care coverage — only covers those who are indigent.

    Federal estimates suggest 70% of people ages 65 and older will need long-term care before they die, but only 3% to 4% of Americans age 50 and older are paying for long-term care policies, according to insurance industry figures.

    The high cost of premiums for those private long-term care policies puts it out of reach for most people.

    Even some who have this kind of insurance find it doesn’t provide enough to cover the costs of home health aides, assisted-living facilities or nursing homes.

    “People think that long-term care insurance is for everyone — but it is not,” said Jessie Slone, executive director of the American Association for Long-term Care Insurance, an advocacy group. “It’s for a very small subset of individuals who plan, and have some retirement assets and income they can use to pay for it.”

    To qualify, applicants need to pass a health review. Slone said insurance companies have underwriting policies with “page after page” of conditions that will disqualify people from getting that coverage.”If you live a long life, the chances of you needing care are significant. So then the issue becomes who’s going to provide for that care, and who’s going to pay for it. For some, long-term care insurance is an option.”

    Prices vary, based on the age when people apply, how good their health is at the time, and how much coverage they want. “You have to start looking at this generally in your 50s or 60s,” Slone said. “Because, as you get older, you’re going to have conditions which insurers are going to look at, determine that you’re very likely to need long-term care and not give you a policy.”

    That coverage, if you can get it, doesn’t come cheap: In 2023, the annual average cost for a policy for a couple both age 55, taking out a $165,000 initial pool growing at 3% compounded annually — ranged from a low of $5,018 to $14,695 a year, according to the association.

    But, compared to auto insurance — which most people may never use — long-term care insurance is a good investment for those who can afford it, Slone said. “Car insurance is the most expensive insurance you ever pay because the chances of you getting into a car accident are somewhat remote. But the chances of someone needing long-term care if they make it to 90 are pretty significant.”

    Lori Smetanka, executive director of the National Consumer Voice for Quality Long-Term Care, a national nonprofit advocacy group, views it differently. She said the private long-term care insurance system has become a “bust” amid rising premiums and difficulties accessing benefits.

    Consider the fact that the number of companies offering long-term care insurance is declining, while payouts are steadily increasing as the baby boomer generation ages.”Most people have found it very expensive,” Smetanka said. “But, at the same time, people are finding that it wasn’t covering what they needed.”

    Last year, insurers paid a record of more than $14 billion to cover an estimated 353,000 long-term care claims, according to industry figures. That’s compared to about $11.6 billion just three years ago.

    Currently, there are about 7.5 million people in the U.S. age 65 and older with private long-term care insurance, according to industry data.

    With that incentive, some states, including Washington and California, are looking at creating long-term care social insurance pools funded by payroll taxes and other sources of funding. The effort also is being spurred, in part, by the rising costs borne by states for Medicaid long-term care coverage, which they share with the federal government.

    “More and more states are coming to the conclusion that this is an under-funded system,” said Marc Cohen, a researcher and co-director of the LeadingAge LTSS Center at the University of Massachusetts at Boston. “There are simply not enough dollars going into the system – given the needs and the demands of the growing elderly population.”

    So far, Washington is the only state to try to address the issue. A law approved by the state Legislature in 2019 created a long-term care benefit program, which provides residents with up to $36,500 to pay for costs such as caregiving, wheelchair ramps, meal deliveries and nursing home fees.

    The Cares Funds is covered by a payroll tax that deducts 0.58% out of paychecks but guarantees a $36,500 lifetime benefit for those who have paid into the fund for 10 years.

    Several other states are studying the issue. In California, a task force is looking at how to design a long-term care program, according to the National Conference of State Legislatures. Massachusetts, Illinois and Michigan also are weighing the costs versus benefits of creating a state long-term care benefits program.

    But the issue of imposing new taxes to pay for long-term care insurance is controversial — and politically unpopular — on both a state and federal level.

    Washington’s long-term care insurance law is facing a repeal effort from a group backed by hedge fund executive Brian Heywood that argues the system should be voluntary. Voters in November will decide whether to allow people to opt out, which supporters say would essentially gut the program.

    “There are a lot of states that are looking to see what happens in Washington,” Cohen said. “If this billionaire who is funding this repeal effort wins, it will be a real blow.”

    Cohen said efforts on a federal level to create a publicly funded insurance pool haven’t gained much traction. A long-term care program created by Congress through the CLASS Plan, which was tied to the Affordable Care Act, was voluntary. That law was repealed in early 2013.

    “It never got off the ground before it was repealed,” he said. “With the dysfunction in Congress, we’re likely to see more action on a state level than the federal.”

    Recent polls suggest there may be some public support for the move. A survey by the National Council on Aging found more than 90% of the 1,000 female respondents across party lines support the idea of creating a government program to pay for the cost of long-term care.

    “The level of support was significant, and very bipartisan,” said Howard Bedlin, a long-term care expert with the council. “People keep talking about how Congress can’t find bipartisan support. Well, the voters clearly support it.

    “The politicians just aren’t giving these issues the attention they deserve.”

    Christian M. Wade is a reporter for North of Boston Media Group.

    [ad_2]

    By Christian M. Wade | CNHI News

    Source link

  • Report: Injured workers at risk for opioid overdoses

    Report: Injured workers at risk for opioid overdoses

    [ad_1]

    Workers who are injured on the job are at higher risk for fatal opioid-related overdoses, according to a new study, which calls for renewed efforts to reduce the stigma of drug addiction.

    The report, released Thursday by the state Department of Public Health, found that working-age Massachusetts residents who died between 2011 and 2020 were 35% more likely to have died of an opioid-related overdose if they had previously been injured at work.

    DPH researchers compiled information about individuals’ employment and work-related injury status from their workers’ compensation claims and linked it with data from their death certificates.

    Researchers reviewed the details of 4,304 working-age adults who died between 2011 and 2020 and found at least 17.2% had at least one workplace injury claim and died of an opioid-related overdose, according to the study.

    Public health officials say the study is the first linking the impact of work-related injuries to opioid-related overdose deaths.

    “Occupational injuries can take both a physical and mental toll, and those who suffer injuries at work may be discouraged from seeking help because of stigmatization and fear of losing their jobs,” Health and Human Services Secretary Kate Walsh said in a prepared statement. “Avoiding or delaying care can lead to a preventable overdose death.”

    She called for stepped-up efforts to “eliminate the stigma that accompanies substance use disorder in all sectors of society, including the workplace.”

    The release of the report comes as opioid overdose deaths remain devastatingly high in the Bay State, despite a slight decrease over the past year.

    There were 2,323 confirmed or suspected opioid-related deaths in Massachusetts from Oct. 1, 2022 to Sept. 30, 2023 — eight fewer than the same period in 2021, according to a report released in December by the health department.

    Health officials attributed the persistently high death rates to the effects of an “increasingly poisoned drug supply,” primarily with the powerful synthetic opioid fentanyl.

    Fentanyl was present in 93% of the overdose deaths where a toxicology report was available, state officials noted.

    Curbing opioid addiction has been a major focus on Beacon Hill for a number of years with hundreds of millions of dollars being devoted to expanding treatment and prevention efforts.

    The state has set some of the strictest opioid prescribing laws in the nation, including a cap on new prescriptions in a seven-day period and a requirement that doctors consult a state prescription monitoring database before prescribing an addictive opioid.

    The Opioid Recovery and Remediation Fund, created by the state Legislature in 2020, has received more than $101 million from settlements with drug makers and distributors over their alleged role in the opioid crisis, according to the Executive Office of Health and Human Services.

    More than 25,000 people have died from opioid-related overdoses in Massachusetts since 2011, according to state records.

    Nationally, fatal drug overdoses fell by roughly 3% in 2023, according data from the U.S. Centers for Disease Control and Prevention.

    But the toll from fatal overdoses in 2023 remained high, claiming 107,543 lives, the federal agency said.

    Fentanyl and other synthetic opioids were responsible for about 70% of lives lost, while methamphetamine and other synthetic stimulants are responsible for about 30% of deaths, the CDC said.

    “The shift from plant-based drugs, like heroin and cocaine, to synthetic, chemical-based drugs, like fentanyl and methamphetamine, has resulted in the most dangerous and deadly drug crisis the United States has ever faced,” Anne Milgram, head of the Drug Enforcement Administration, said in a recent statement.

    The DEA points to Mexican drug cartels, who it says are smuggling large quantities of fentanyl and other synthetic drugs manufactured in China into the country, along the southern border.

    “The suppliers, manufacturers, distributors, and money launderers all play a role in the web of deliberate and calculated treachery orchestrated by these cartels,” she said.

    [ad_2]

    By Christian M. Wade | Statehouse Reporter

    Source link

  • Report: Injured workers at risk for opioid overdoses

    Report: Injured workers at risk for opioid overdoses

    [ad_1]

    Workers who are injured on the job are at higher risk for fatal opioid-related overdoses, according to a new study, which calls for renewed efforts to reduce the stigma of drug addiction.

    The report, released Thursday by the state Department of Public Health, found that working-age Massachusetts residents who died between 2011 and 2020 were 35% more likely to have died of an opioid-related overdose if they had previously been injured at work.

    DPH researchers compiled information about individuals’ employment and work-related injury status from their workers’ compensation claims and linked it to data from their death certificates.

    Researchers reviewed the details of 4,304 working-age adults who died between 2011 and 2020 and found at least 17.2% had at least one workplace injury claim and died of an opioid-related overdose, according to the study.

    Public health officials say the study is the first linking the impact of work-related injuries to opioid-related overdose deaths.

    “Occupational injuries can take both a physical and mental toll, and those who suffer injuries at work may be discouraged from seeking help because of stigmatization and fear of losing their jobs,” Health and Human Services Secretary Kate Walsh said in a statement. “Avoiding or delaying care can lead to a preventable overdose death.”

    Walsh called for stepped-up efforts to “eliminate the stigma that accompanies substance use disorder in all sectors of society, including the workplace.”

    The release of the report comes as opioid overdose deaths remain devastatingly high in the Bay State, despite a slight decrease over the past year.

    There were 2,323 confirmed or suspected opioid-related deaths in Massachusetts from Oct. 1, 2022, to Sept. 30, 2023 — eight fewer than the same period in 2021, according to a report released in December by the health department.

    Health officials attributed the persistently high death rates to the effects of an “increasingly poisoned drug supply,” primarily with the powerful synthetic opioid fentanyl.

    Fentanyl was present in 93% of the overdose deaths where a toxicology report was available, state officials noted.

    Curbing opioid addiction has been a major focus on Beacon Hill for a number of years with hundreds of millions of dollars being devoted to expanding treatment and prevention efforts.

    The state has set some of the strictest opioid-prescribing laws in the nation, including a cap on new prescriptions in a seven-day period and a requirement that doctors consult a state prescription monitoring database before prescribing an addictive opioid.

    The Opioid Recovery and Remediation Fund, created by the state Legislature in 2020, has received more than $101 million from settlements with drug makers and distributors over their alleged role in the opioid crisis, according to the Executive Office of Health and Human Services.

    More than 25,000 people have died from opioid-related overdoses in Massachusetts since 2011, according to state records.

    Nationally, fatal drug overdoses fell by roughly 3% in 2023, according data from the U.S. Centers for Disease Control and Prevention.

    But the toll from fatal overdoses in 2023 remained high, claiming 107,543 lives, the federal agency said.

    Fentanyl and other synthetic opioids were responsible for approximately 70% of lives lost, while methamphetamine and other synthetic stimulants are responsible for approximately 30% of deaths, the CDC said.

    “The shift from plant-based drugs, like heroin and cocaine, to synthetic, chemical-based drugs, like fentanyl and methamphetamine, has resulted in the most dangerous and deadly drug crisis the United States has ever faced,” Anne Milgram, head of the Drug Enforcement Administration, said in a recent statement.

    The DEA points to Mexican drug cartels, who it says are smuggling large quantities of fentanyl and other synthetic drugs manufactured in China into the country along the southern border.

    “The suppliers, manufacturers, distributors, and money launderers all play a role in the web of deliberate and calculated treachery orchestrated by these cartels,” she said.

    Christian M. Wade covers the Massachusetts Statehouse for North of Boston Media Group’s newspapers and websites. Email him at cwade@cnhinews.com.

    [ad_2]

    By Christian M. Wade | Statehouse Reporter

    Source link

  • Local doctor to head state medical society

    Local doctor to head state medical society

    [ad_1]

    A longtime North Shore doctor has won election as the 142nd president of the Massachusetts Medical Society.

    Hugh Taylor, of Ipswich, who has been practicing as family physician in Hamilton for 41 years, will lead the statewide professional organization of physicians and medical students for a one-year term ending in May 2025.

    Taylor has been an Massachusetts Medical Society member since 1983, and he’s a past president of the Essex South District Medical Society.

    He serves on the board of trustees of Beverly Hospital as well as Addison Gilbert Hospital in Gloucester, where he is a past president of the medical staff.

    The 25,000-member Massachusetts Medical Society has its main offices in Waltham with regional offices in Lakeville and Wilbraham.

    [ad_2]

    By News Staff

    Source link

  • Police/Fire: Gloucester woman held, accused of driving stolen Audi while drugged

    Police/Fire: Gloucester woman held, accused of driving stolen Audi while drugged

    [ad_1]

    After a report of an Audi SUV driving erratically in the vicinity of the Bass Avenue traffic lights and East Main Street just after 5 a.m.last Monday, police arrested a 43-year-old Gloucester woman on charges of larceny of a motor vehicle; driving under the influence of drugs, a third offense; driving with a suspended license; negligent driving; a marked lanes violation; and receiving a stolen motor vehicle.

    Kimberly A. Ahearn, of 11 Chestnut St., Apt. 4, was ordered held without bail during her arraignment last Monday in Gloucester District Court. She was scheduled for a detention hearing this Monday, May 20, according to the district court’s clerk’s office.

    The person reporting the blue Audi SUV being driven erratically said it was “flying,” and believed it to be going in excess of 100 mph. The following driver said the Audi appeared to attempt to evade him, driving so fast and erratically he was no longer able to safely follow it.

    Earlier that morning, at 4:15, police had gone to Edgemoor Road for a report of a woman ringing a homeowner’s doorbell, with the resident reporting the woman appeared “hammered.” This caller said the woman came from what appeared to be a dark-colored Audi SUV.

    The Audi was reported to have gone down East Main Street toward Zeke’s Restaurant. Officers spotted the vehicle and dispatch informed them the vehicle came back to an address on Eastern Point Boulevard. Police followed the Audi as it weaved down the road and nearly struck the curb. Police stopped the car just before the stop sign heading toward Bass Avenue.

    Police approached the driver and noted a strong odor of heavy brake use coming from the SUV. The officer reported recognizing the driver as she had several run-ins with police recently and in the past, the report said. She reportedly laughed hysterically when the officer tried to speak with her and eventually the officer was able to confirm her identity. When asked if the Audi belonged to her, she said she came out of her apartment on Chestnut Street, saw the vehicle with its keys in the cup holder, and took it, the report said. Police informed her this was a crime, which she denied and said she needed the vehicle to get around to do errands. Ahearn said she did not have her license on her and it was confirmed her license was suspended.

    When she got out to take field sobriety tests, police noticed she was not wearing shoes. Police said she showed signs of impairment while taking the tests. Police contacted the Audi’s owner who told police she did not give anyone permission to use her car. The owner was given a ride to the scene where she saw damage to the Audi’s front driver’s side bumper that had not been there before. Police subsequently arrested Ahearn.

    — Ethan Forman

    In other news taken from the logs of Cape Ann’s police and fire departments:

    GLOUCESTER

    Tuesday, May 14

    9:08 p.m.: Debris in the roadway was located on Rockland Street.

    6:40 p.m.: Police responded to a report from a Viking Street homeowner who said someone in a maroon sedan pulled in her driveway and started taking pictures of her house. She told police she came out from behind her vehicle and approached the man who told her he was taking pictures for FEMA. The man did not show any ID and left abruptly. She was unable to get the plate number of the sedan. Police were given a description of a man who was large in stature wearing a black shirt with the letters “OSI” on it. Police advised the woman to lock her doors and call if the vehicle returned.

    3:23 p.m.: Police responded to a disturbance at Good Harbor Beach on Thatcher Road.

    Crashes with property damage only were reported at East Main and Wall streets at 11:17 a.m., and on Grant Circle on Route 128 north at 2:40 p.m.

    12:14 p.m.: Peace was restored after a caller reported juveniles drinking on Good Harbor Beach on Thatcher Road.

    11:06 a.m.: Fraud was reported on Elizabeth Road.

    Monday, May 13

    10:42 p.m.: Police responded to a report of a disabled vehicle in the roadway on Concord Street.

    6:20 p.m.: A 27-year-old Gloucester resident was arrested on charges of possession of a Class B drug, larceny under $1,200, disorderly conduct and resisting arrest after police responded to Oak and Warner streets for report of a person hitting another person with a bat.  Police also filed a complaint against a 53-year-old on a charge of assault with a dangerous weapon.

    5:29 p.m.: Police planned to file a criminal complaint against a Gloucester resident in relation to a report of past harassment/domestic assault and battery.

    4:24 p.m.: Police assisted the Fire Department with an active fire on East Main Street. The road was closed at Chapel Street. Officers arrived to find an outside structure fire. Traffic was detoured around the fire site and the Fire Department responded to extinguish it.

    3:35 p.m.: A caller from Staten Street reported his neighbor has a camera intentionally facing his backyard.

    Crashes with property damage only were reported on Grant Circle at 11:23 a.m., Prospect Street at 12:03 p.m., and Route 128 northbound at 3:19 p.m..

    10:57 a.m.: Police took a report of credit card fraud.

    10:26 a.m.: Police responded to a disturbance at the 1-4, C-2 lot on Rogers Street.

    4:16 a.m.: A disturbance was reported on Edgemoor Road.

    ESSEX

    Thursday May 16

    10:46 p.m.: Suspicious activity was reported at a Centennial Grove Road address.

    7:51 p.m.: A police investigation was conducted at an Essex Avenue address.

    Individuals were assisted on Western Avenue at 8:44 a.m., John Wise Avenue at 4:31 p.m. and Harry Homans Drive at 5:17 p.m.

    11:51 a.m.: A call was made for a community policing event at a Martin Street address.

    MANCHESTER

    Thursday, May 16

    6:23 p.m.: After a motor vehicle stop on School Street, a written warning was issued.

    2:25 p.m.: A report was made about lost and found property at a Beach Street address.

    1:49 p.m.: A disturbance was reported at a School Street address.

    Individuals were assisted on Highland Avenue at 11:53 a.m., and Central Street at 8:18 a.m. and 1:10 p.m.

    Police investigations were conducted on Crooked Lane at 9:41 a.m. and Federal Street at 11:40 a.m.

    9:40 a.m.: A fire alarm, reported at a Bridge Street address, was later determined to be a false alarm.

    [ad_2]

    Source link